Assembly Biosciences (ASMB) Current Assets (2010 - 2026)

Assembly Biosciences' Current Assets history runs 17 years deep, the most recent figure standing at $232.6 million for Q1 2026.

• In Q1 2026, Current Assets rose 143.5% year-over-year to $232.6 million; the TTM figure through Mar 2026 stood at $232.6 million (up 143.5% YoY), while the FY2025 annual figure was $254.5 million, up 120.38% from the prior year.
• Current Assets for Q1 2026 stood at $232.6 million, down from $254.5 million in the prior quarter.
• The five-year high for Current Assets was $254.5 million in Q4 2025, with the low at $49.7 million in Q3 2023.
• The 5-year median for Current Assets is $115.1 million (2022), against an average of $125.6 million.
• The sharpest annual moves came in 2023 and 2026: Current Assets sank 56.84% in 2023, then jumped 143.5% in 2026.
• Assembly Biosciences' Current Assets stood at $97.0 million in 2022, then soared by 37.97% to $133.8 million in 2023, then slipped by 13.67% to $115.5 million in 2024, then jumped by 120.38% to $254.5 million in 2025, then dropped by 8.62% to $232.6 million in 2026.
• Business Quant data shows ASMB's Current Assets at $232.6 million in Q1 2026, $254.5 million in Q4 2025, and $236.8 million in Q3 2025.